Gene therapy for haemophilia: an update on progress in clinical trials

Open access

Abstract

Clotting factor replacement therapy has proven a highly effective means of treating haemophilia A and B. But treatment involves frequent and lifelong infusion of factor concentrates and is generally prophylactic rather than curative. It is also extremely expensive, associated with inhibitor formation and does not fully abolish the potential for spontaneous bleeding. Gene therapy offers a potential cure for haemophilia, with the possible continuous expression of a clotting factor gene following the administration of a viral vector carrying the appropriate gene. Recent clinical trials of gene therapy for haemophilia have proven positive in selected patients and new studies are underway.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Cancio MI Reiss UM Nathwani AC et al. Developments in the treatment of hemophilia B: focus on emerging gene therapy. Appl Clin Genet 2013; 6: 91-101. doi:

    • Crossref
    • Export Citation
  • 2. Gringeri A Ewenstein B Reininger A. The burden of bleeding in haemophilia: is one bleed too many? Haemophilia 2014; 20(4): 459-63. doi:

    • Crossref
    • Export Citation
  • 3. Schrijvers LH Uitslager N Schuurmans MJ Fischer K.Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia 2013 5; 19(3): 355-6. doi:

    • Crossref
    • Export Citation
  • 4. Kaufman RJ Powell JS. Molecular approaches for improved clotting factors for haemophilia. Hematology Am Soc Hematol Educ Program 2013; 2013: 30-6. doi:

    • Crossref
    • Export Citation
  • 5. Chuah MK Evens H VandenDriessche T. Gene therapy for hemophilia. J Thromb Haemost 2013; 11 Suppl 1: 99-110. doi:

    • Crossref
    • Export Citation
  • 6. Porada CD Stem C Almeida-Porada G. Gene Therapy; The promise of a permanent cure. N C Med J 2013; 74(6): 526-9.

  • 7. Snyder RO Miao C Meuse L et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 5(1): 64-70.

  • 8. Mount JD Herzog RW Tillson DM et al. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 2002; 99(8): 2670-6.

  • 9. High KA. The gene therapy journey for hemophilia: are we there yet? Blood 2012; 120(23): 4482-7. doi:

    • Crossref
    • Export Citation
  • 10. Mingozzi F High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy Blood 2013; 122(1): 23-36. doi:

    • Crossref
    • Export Citation
  • 11. Roth DA Tawa NE O’Brien JM et al. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe haemophilia A. N Engl J Med 2001; 344(23): 1735-1742.

  • 12. Powell JS Ragni MV White GC et al. Phase 1 trial of FVIII gene transfer for severe haemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood 2003; 102(6): 2038-2045.

  • 13. White GC Monahan PE. Gene therapy for haemophilia A. In: Lee CA Berntorp EE Hoots K editors. Textbook of Haemophilia. 2nd ed. Hoboken NJ: Wiley- Blackwell; 2005.

  • 14. Manno CS Chew AJ Hutchison S et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe haemophilia B. Blood 2003; 101(8): 2963- 2972

  • 15. Manno CS Pierce GF Arruda VR et al. Successful transduction of liver in haemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12(3): 342-347.

  • 16. Nathwani AC Tuddenham EG Rangarajan S et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357-65. doi:

    • Crossref
    • Export Citation
  • 17. Nathwani AC Reiss UM Tuddenham EG et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med 2014; 371: 1994-2004. doi:

    • Crossref
    • Export Citation
  • 18. http://www.fda.gov/

  • 19. Pick A Gilbert K McCaul J. The role of effective communication in achieving informed consent for clinical trials. Nurs Stand 2014 Nov 5;29(10):45-8. doi:

    • Crossref
    • Export Citation
Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 154 88 1
PDF Downloads 120 78 6